Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Alfred Cook

Orthopaedic Surgery The Villages, FL Medical Doctor

NPI 1861650145 CMS profile 220424

1400 N US Highway 441 Ste 552, The Villages, FL 32159

Open in the dashboard

General payments

$221,416

112 records reported · program years 2019–2025

Research payments

$336,387

Paid to them · 3 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Alfred Cook of The Villages, FL is reported in the CMS Open Payments database as having received $221,416 across 112 general payments and $336,387 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $75,463 13
2025 Research $124,317 1
2024 General $50,821 18
2024 Research $122,071 1
2023 General $46,849 24
2023 Research $90,000 1
2022 General $6,702 18
2021 General $14,635 15
2020 General $12,701 10
2019 General $14,246 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alfred Cook
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Alfred Cook were reported at $75,463. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Alfred Cook Orthopaedic Surgery median Middle half National median
2019 $14,246 $644 $140–$2,844 $163
2020 $12,701 $312 $75–$1,860 $114
2021 $14,635 $520 $117–$2,495 $132
2022 $6,702 $598 $128–$2,731 $149
2023 $46,849 $461 $128–$2,264 $160
2024 $50,821 $497 $134–$2,475 $164
2025 $75,463 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. FX Shoulder USA, Inc $216,430 25 payments
  2. Smith+Nephew, Inc. $2,678 29 payments
  3. Next Science LLC $679 4 payments
  4. CGG Medical Inc $349 5 payments
  5. Bone Support Inc. $116 1 payment
  6. Bioventus LLC $114 5 payments
  7. Zimmer Biomet Holdings, Inc. $108 2 payments
  8. Orthogenrx Inc. $103 6 payments
  9. MicroPort Orthopedics Inc $100 2 payments
  10. Dynasplint Systems Inc. $92 1 payment
  11. Other $647 32 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $156,841 5 payments
  2. Consulting Fee $26,845 3 payments
  3. Travel and Lodging $17,788 12 payments
  4. Honoraria $7,500 1 payment
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $6,067 1 payment
  6. Food and Beverage $5,478 89 payments
  7. Education $898 1 payment
Products named General payments · program years 2019–2025
  1. FX V 135 Stem $46,637 1 payment
  2. B1130S0HO170460|SHOULDER INNOVATIONS TSA $6,350 1 payment
  3. B1132N2SN064401|SHOULDER INNOVATIONS HUMERAL SHORT STEM SYSTEM $6,067 1 payment
  4. Bioinductive Implant with Arthroscopic Delivery System - Medium $1,924 14 payments
  5. B1132N2HE210561|SHOULDER INNOVATIONS HUMERAL SHORT STEM SYSTEM $1,871 2 payments
  6. FIRSTPASS $983 4 payments
  7. Xperience $323 1 payment
  8. BLASTX $323 1 payment
  9. SurgX $323 1 payment
  10. Bone Anchors with Arthroscopic Delivery System $292 4 payments
  11. Other $3,072 84 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. FX Shoulder USA, Inc $336,387 3 payments

Prescribing to Medicare patients

Part D · data year 2024 · 15 drugs

Part D claims

1,875

Median for Orthopedic Surgery: 203

Drug cost

$14,739

Median for Orthopedic Surgery: $1,433

Branded share of claims

16.6%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 246 $3,735
Methylprednisolone Generic 473 $3,391
Meloxicam Generic 558 $2,217
Ondansetron Hcl Generic 133 $1,484
Tramadol Hcl Generic 155 $843
Celecoxib Generic 41 $771
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 47 $560
Ibuprofen Generic 16 $413
Ondansetron Odt Ondansetron Brand 18 $357
Cephalexin Generic 70 $340

The 10 drugs with the highest cost, of 15 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 68 billing codes

Paid by Medicare

$704,827

Of which drugs: $92,326

Medicare patients

1,331

Average age 76

Services billed

204,743

784 women, 547 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 41%
Chronic kidney disease 34%
Diabetes 30%
Depression 29%
Atrial fibrillation 24%
COPD 22%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg J7331 Office 52 4,900 $38,662
Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose J7324 Office 36 241 $24,034
Injection, methylprednisolone acetate, 1 mg J1010 Office 659 190,922 $19,550
Injection, methylprednisolone acetate, 80 mg J1040 Office 372 677 $4,348

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Exparel
  • Pacira Pharmaceuticals Incorporated $20
$20 — —
EVENITY
  • Amgen Inc. $7
$7 — —
Prolia
  • Amgen Inc. $7
$7 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

115 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record